Osaka, Japan

Kazayuki Hirata

This inventor holds 1 USPTO granted patent. Top assignee: Japan Tobacco Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazayuki Hirata. Retrieved from https://idiyas.com/inventor/kazayuki-hirata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazayuki Hirata: Innovator in Medicinal Chemistry

Introduction

Kazayuki Hirata is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative research and development of pharmaceutical compounds. His work has the potential to impact various therapeutic areas.

Latest Patents

Hirata holds a patent for an amide compound and its medicinal use. The patent describes a compound of formula [I-W], wherein each symbol is defined in the description, or a pharmaceutically acceptable salt thereof. This invention showcases his expertise in creating compounds that may have valuable applications in medicine.

Career Highlights

Kazayuki Hirata is associated with Japan Tobacco Inc., where he has been involved in research and development efforts. His role at the company has allowed him to focus on innovative solutions in the pharmaceutical sector. With 1 patent to his name, he has established himself as a key figure in his field.

Collaborations

Hirata has collaborated with notable colleagues, including Takaki Maeba and Katsuya Maeda. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Kazayuki Hirata's contributions to medicinal chemistry through his patent and work at Japan Tobacco Inc. highlight his role as an innovator in the field. His research continues to pave the way for potential advancements in pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…